The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 8.7M (2022) → 12.4M (2026)
Established on April 24, 1995, Concord Drugs Limited is a pharmaceutical firm based in Hyderabad, India, dedicated to manufacturing and distributing a broad spectrum of medicinal formulations. Its extensive product line encompasses ready-to-fill pellets, specialized MUP's tissue bio-adhesives, injectable drugs, a variety of oral solid dosages, and liquid oral preparations.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+53.9% YoY
YoY Growth Rate
Revenue accelerating
+608.3% YoY
YoY Growth Rate
EPS growth accelerating
₹0/ year
0.0% of revenue
Below sector average (18%)
Research and development spending
Cash flow positive
₹0 cash & investments
Company generates more cash than it spends — no dilution risk from fundraising
Concord Drugs Limited grew revenue 54% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Earnings growing 25%+ a year. The compounder zone.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
FCF margin between 0% and 10%. Some cash from sales, but not a lot.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Interest coverage between 3 and 8. Profits cover interest several times over.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
P/E over 35. The market is pricing in heavy, sustained growth.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
